- Email: [email protected]
Cumulative Subject Index, Volumes 206–216 (2003)
Journal of the Neurological Sciences 216 (2003) 207 – 213 www.elsevier.com/locate/jns
Cumulative Subject Index, Volumes 206–216 (2003) A Japanese family (210) 91 ABCA1 (210) 11 Acetazolamide (210) 91 Active neuromuscular stimulation (215) 13 Acute disseminated encephalomyelitis (206) 27 Acute inflammatory demyelinating polyneuropathy (210) 105 Acute motor axonal neuropathy (210) 41, (211) 93 Adhesion molecule (215) 119 Adhesion molecules (212) 37 Adult-onset (207) 59 A-y fibers (216) 67 Age (209) 25 Aging (207) 37, (209) 47, (214) 37, (216) 143 AIDS (208) 39 Airway secretions management (209) 111 ALS treatment (209) 111 Alterated splice site (212) 75 Alzheimer’s disease (208) 17, (208) 31, (209) 25, (210) 11, (215) 71, (216) 119, (216) 127 Alzheimer’s disease (AD) (216) 105 21-Aminosteroids (215) 87 AMPA/kainate receptor (206) 91 Amyotrophic lateral sclerosis (206) 65, (206) 91, (207) 51, (208) 67, (209) 79, (210) 83, (211) 85, (213) 47, (216) 95 Amyotrophic lateral sclerosis (ALS) (215) 57 Anatomy (211) 75 Anesthesia (211) 43 Angiocentric immunoproliferative lesions (213) 67 Angioencephalopathy (208) 101 Angiotensin-converting enzyme (210) 77 Anterior spinal artery (207) 1 Antibodies (211) 67 a-1-Antichymotrypsin (210) 77 Anticoagulant therapy (212) 99 Anti-GAD autoantibody (208) 51 Anti-ganglioside antibodies (213) 11 Anti-ganglioside antibody (210) 99, (211) 89 Anti-GM1 antibody (210) 41 Anti-GM1b antibody (210) 41 Anti-GQ1b antibody (210) 105 Anti-GT1a antibody (210) 105 Anti-Hu associated paraneoplastic encephalomyelitis (213) 77 Anti-MAG antibodies (207) 43 Anti-MAG polyneuropathy (207) 43 Antiparkinsonian agents (212) 55 Antiplatelets (207) 5 Anxiolytic effect (211) 5 Apolipoprotein E (210) 77, (211) 15 Apolipoprotein E genotype (206) 31 Apomorphine (215) 105 Apoptosis (207) 51, (208) 17, (214) 27 Apparent diffusion coefficient (216) 11 Architecture (210) 47 Arterial occlusive diseases (207) 65 Artery (212) 79
doi:10.1016/S0022-510X(03)00323-X
Asclepius (213) 15 Ascorbate (215) 51 Assay (208) 1 Association study (209) 87, (213) 7 Astrocytes (208) 9 Asymptomatic stroke (214) 37 Ataxia (210) 53 Atheroscrelosis (207) 19 Atlastin (216) 43 Atopic dermatitis (206) 39 Atopic myelitis (206) 39 Atopy (206) 109, (209) 5 Atrophy (208) 57, (210) 5, (215) 45, (216) 169 Attention (213) 29 Attentional set-shifting (209) 19 Auditory midbrain (216) 143 Australia (213) 1 Autoimmunity (213) 55 Automated (216) 169 Autonomic nervous system (213) 47, (215) 79 Autonomic nervous system disorder (216) 17 Axon (206) 165 Axonal degeneration (210) 41 Axonal injury (206) 187 Axonal neuropathy (214) 3 Axonal transport blockage (211) 29 Axonal transport substances (211) 29 Baculovirus p35 gene (216) 135 Baroreflex (213) 47 Basal ganglia (206) 27 aB-crystallin (206) 71 BDNF (215) 37 Best frequency (216) 143 Bickerstaff’s brainstem encephalitis (211) 89 Bilateral frontal polymicrogyria (213) 83 Binding antibody (215) 3 Blood – brain barrier (215) 87 Blood donors (214) 49 Body fluids (208) 1 Body weight (206) 85 Bovine gangliosides (216) 99 Brain (210) 11, (210) 23 Brain death (210) 31 Brain edema (215) 87 Brain infarction (210) 95 Brain ischemia (212) 99 Brain parenchymal fraction (208) 57 Brainstem (208) 93, (208) 101 CAG repeat (215) 45 CAG repeats (216) 47 Calculation (208) 31 Campylobacter jejuni (210) 41, (210) 99, (213) 55 Cardiac autonomic modulation (216) 153
208
Cumulative Subject Index, Volumes 206 – 216 (2003)
Cardiac [123I]-MIBG-SPECT (216) 153 Cardioembolism (212) 99 Caregiver (209) 79 Carotid artery (207) 19, (210) 31, (213) 19 Carotid endarterectomy (213) 19 Cauda equina (208) 113 Caudate nucleus (216) 109 CCM (212) 75 CD29 (216) 61 CD4 count (208) 39 Central autonomic nervous system diseases (215) 79 Central conduction time (210) 83 Central core disease (206) 71 Central nervous system (213) 67 Cerebellar ataxia (208) 51, (216) 183 Cerebellum (208) 51, (213) 35 Cerebral (216) 169 Cerebral autoregulation (208) 71 Cerebral blood flow (208) 71, (213) 19 Cerebral edema (209) 69 Cerebral infarction (209) 69, (212) 79 Cerebral spinal fluid (CSF) (206) 145 Cerebral venous thrombosis (215) 9 Cerebrospinal fluid (207) 71, (208) 39, (211) 67, (212) 11 Cerebrotendinous xanthomatosis (216) 179 Cerebrovascular disorders history (213) 15 Cervical spondylosis (206) 39 Chaperonin 10 (212) 37, (216) 33 Charcot – Marie – Tooth disease (210) 61, (211) 93 Chemokine (208) 43 Chemokine receptor (216) 61 Chemoreflex (213) 47 Chenodeoxycholic acid (216) 179 Chinese (216) 55, (216) 81, (216) 163 Cholestanol (216) 179 Cholesterol (210) 11 Cholinesterase inhibitors (216) 119 Chorea (208) 109 Christus Medicus (213) 15 Chromosome 19 (213) 7 Chronic brain inflammation (212) 69 Chronic inflammatory demyelinating polyneuropathy (208) 39 Chronic inflammatory demyelinating polyneuropathy (CIDP) (208) 43, (210) 19 Circadian rhythm (212) 93 Circumscribed atrophy (209) 105 Citicoline (215) 105 Citrullinaemia (209) 101 Clinical characteristics (206) 131 Clinical Dementia Rating (215) 71 Clinical epidemiology (215) 63 Clinical – MRI correlation (206) 139 Clustering/random arrangement (211) 63 CMTX (207) 77 CNS inflammation (206) 49 Coagulation system (212) 55 Coffee (216) 163 Cognitive function (213) 19 Cognitive functions (211) 15 Cognitive impairment (216) 105 Color discrimination (213) 61 Color vision (213) 61 Combined treatment (216) 179 Complex III deficiency (208) 87 Complex partial status epilepticus (213) 77 Complication (209) 115 Computed tomography (CT) (208) 93
Conduction block (213) 11 Congenital hypomyelination (210) 61 Congenital myopathies (206) 71 Connexin 32 mutation (207) 77 Controlled trials (206) 123 Coordinated eye and head movements (213) 35 CopaxoneR (215) 37 Cores (206) 71 Cortex (211) 85 Cortical excitability (215) 75 Cortical threshold (210) 83 Corticobasal degeneration (206) 97, (208) 31, (216) 127 Corticobasal degeneration syndrome (216) 127 Corticosteroids (208) 113 CSF (206) 43, (207) 87 CTG repeat (207) 31 CT scan (208) 25 Cultured neurons (206) 91 Cutaneous silent period (216) 67 Cu/Zn superoxide dismutase gene (206) 65 CXCR3 (216) 61 D-Cycloserine (210) 53 Cytoarchitecture (211) 75 Cytochrome b mutation (209) 61 Cytochrome c oxidase deficiency (211) 63 Cytochrome oxidase (212) 93 Cytokine (208) 43, (213) 11 Cytokines (215) 95, (216) 33 Cytomegalovirus (213) 55 Decreased saccadic latency (213) 35 Dejerine – Sottas syndrome (210) 61 Delayed-type hypersensitivity reaction (212) 37 Dementia (206) 23, (208) 87, (209) 105, (210) 77, (212) 79, (214) 37, (216) 119, (216) 169 Dementia with Lewy bodies (211) 29 Dementia with Lewy bodies (DLB) (216) 105 Demyelination (206) 187, (210) 19, (212) 37 Depression (209) 79, (211) 55 Developing country (209) 65 DGGE (210) 61 Diagnosis (210) 31 Diffuse brain disorders (213) 29 Diffuse neurofibrillary tangles with calcification (209) 105 Diffusion tensor (206) 157 Diffusion tensor MRI (206) 27 Diffusion-weighted imaging (210) 95, (212) 99 Diffusion-weighted MR (209) 101 Digit backward span (209) 19 Disability (206) 165, (206) 209, (209) 65 Disability evaluation (208) 57 Disease activity (211) 67 Disease progression (206) 123 Disuse (210) 5 L-DOPA sensitive Dystonia (213) 25 Dopamine (208) 9 Dopamine transporter gene (209) 87 Doppler (207) 65, (208) 71 Dose response (214) 43 Dural arteriovenous fistula (215) 115 Dynamics (212) 47 Dysconjugacy (210) 65 Dysferlin (211) 23 Dystonia (206) 59 EAE (206) 49 Early ischemic change (212) 99
Cumulative Subject Index, Volumes 206 – 216 (2003) Early pregnancy factor (212) 37, (214) 27, (216) 33 Education, Personality (211) 15 EEG (213) 83 Efficacy (211) 81 EGR2 (210) 61 Electromyography (214) 21 Electron transport chain (206) 23 Electrophysiological study (211) 89 Elevated plus-maze test (211) 5 ELISA (207) 43 Emery-Dreifuss (210) 47 Endothelin-1 (212) 59 Endplate (210) 5 Epidemiology (212) 31, (213) 1, (214) 7 Epidermal nerve fibers (214) 3 Epilepsy (209) 65, (213) 83 Epilepsy/EEG (211) 37 Epilepsy surgery (216) 153 Episodic ataxia type 2 (EA-2) (210) 91 Epitope mapping (206) 7 Epitope specificity (206) 7 Estrogen (210) 11 Etanercept (EnbrelR) (210) 19 Evan’s blue (215) 87 Evoked potentials, Auditory (212) 1 Exercise intolerance (209) 61 Exonic deletion (207) 11 Experimental autoimmune encephalomyelitis (212) 37, (214) 27, (216) 33 Exteroceptive suppression (216) 67 Eye/head latencies (213) 35 Fabry’s disease (214) 21 Falls (212) 47 Familial ALS (206) 65 Familial Alzheimer’s disease (209) 75 FDG PET (212) 85 Femoral neuropathy (209) 119 [F-18]-FDG (210) 23 Fibrinolysis (212) 55 Filamin C (206) 71 First-pass amplitude (210) 65 Flexion myelopathy (206) 109 Flow cytometry (209) 93 Fluorodeoxyglucose (FDG) (215) 71 fMRI (213) 29 Folate (207) 19 Four-vessel occlusion (215) 87 Frequency (211) 23 Friedreich’s ataxia (206) 59 Frontal cortex (209) 41 Frontal lobe function (214) 37 Frontotemporal dementia (206) 97, (208) 31 Functional magnetic resonance imaging (206) 157 Functional status (209) 65 GABA (208) 51 GABAA receptor (208) 51 GABAB receptor (208) 51 Gadolinium enhancement (213) 67 Gait (212) 47 Galectin-1 (208) 67 Gallium scan (208) 113 Ganglioside (213) 55 Gastric haemorrhage (208) 25 Gene analysis (210) 91 Gene dosage analysis (207) 11 Gene expression in Andeans (207) 37
209
Gene regulation (215) 95 Genetic polymorphism (209) 87 Genetics (213) 7 Genotype (210) 77 Giant cell arteritis (215) 27 Glatiramer acetate (215) 37 Glia (209) 31 Glioma (216) 1 Glutamate (206) 91 Glutamic acid decarboxylase (208) 51 Glutathione (207) 51, (215) 105 GM1 (210) 99 GQ1b (211) 89 Guillain – Barre´ syndrome (208) 39, (210) 99, (211) 93, (213) 11, (213) 55, (216) 99 Guillain-Barre´ syndrome (210) 41, (211) 89 Guillain – Barre´ syndrome (GBS) (215) 63 Habituation (212) 1 HAM/TSP (207) 87 Haploinsufficiency (210) 35 Haplotype (207) 11 Health-related quality of life (211) 55 Heart rate variability (216) 153 Heat shock protein (216) 33 Helicobacter pylori (213) 55 Hemiplegia (213) 15 Heparanase (206) 49 Heparin-mimicking polyanionic compound (HMPAC) (206) 49 Hepatic cirrhosis (212) 93 Hepatic encephalopathy (212) 93 Hereditary motor and sensory neuropathies (207) 77 Hereditary spastic paraplegia (216) 43 Heteroplasmy (211) 63 Hippocampus (209) 31 History of medicine, Medieval (213) 15 HIV (208) 39 HLA (211) 49 HMG-CoA reductase inhibitor (216) 179 1H-MRS (215) 21 HMSN (210) 61 H2O2 (216) 135 Homocysteinemia (207) 19 Hourglass-like fascicular constriction (215) 111 HTLV-I (206) 17, (207) 87, (214) 49 HTLV-I antibody index (207) 87 HTLV-I associated myelopathy (206) 17 HTLV-I-associated myelopathy (214) 49 HTLV-I-associated myelopathy/tropical spastic paraparesis (207) 87 Human chronic hypoxia (207) 37 Huntington’s disease (212) 1 6-hydroxydopamine (215) 105 Hyperbaric oxygenation (209) 115 Hypertension (208) 93 Hypothermia (209) 55 Hypoxia (206) 187, (213) 47, (215) 57 ICAM-1 (211) 15 ICAM-1 meningitis (206) 43 Idiopathic intracranial hypertension (215) 9 IgE (209) 5 IL-8 (206) 43 IL-10 (206) 209 Iliacus muscle hematoma (209) 119 IL-23, IL-12, IL-23R, IL-12R (215) 95 Immunoblotting (211) 23 Immunocytochemistry (209) 31
210
Cumulative Subject Index, Volumes 206 – 216 (2003)
Immunoglobulin G (206) 123 Immunoglobulins (206) 7 Immunohistochemistry (207) 43, (208) 67, (211) 23, (215) 119 Immunomodulation (206) 49 Immunosuppression (206) 203 Impedance cardiography (208) 71 Incidence (213) 1, (216) 89, (216) 99 Increased saccadic velocity (213) 35 Inflammatory demyelination (212) 21 Inflammatory myopathy (215) 119 Information processing (213) 29 Insert mutation (210) 35 In situ hybridisation (215) 27 Insula (212) 85 Interferon-h (207) 59 Interferon beta (206) 199, (216) 113 Interferon beta-1a (206) 215 Interferon beta 1a (215) 3 Interferon beta 1b (215) 3 Interferon-gamma (209) 93 Interleukin-6 (211) 15 International cooperative ataxia rating scale (210) 53 Internuclear ophthalmoparesis (210) 65 Intervertebral disc degeneration (206) 39 Intracerebral haemorrhage (208) 25 Intracranial hypertension (215) 9 Intracranial large artery disease (216) 55 Intracranial sinus venous thrombosis (215) 9 Intramedullary spinal cord lesion (216) 67 Intrathecal (211) 81 Intrathecal IgG synthesis (212) 69 Intravenous immunoglobulin (206) 123, (210) 105 Intravenous immunoglobulin (IVIg) therapy (208) 43 Intraventricular hemorrhage (215) 115 In vivo microdialysis (211) 5 Iopamidol transfer (206) 85 Isatin (206) 79 Ischemic cerebrovascular disease (206) 31 Ischemic stroke (207) 5 Isoelectric focusing (212) 69 Japanese (211) 49 Japanese encephalitis virus (206) 79 Japanese pedigree (209) 75 Korean family (206) 65 Kosaka – Shibayama disease (209) 105 KRIT1 gene (212) 75 Laboratory markers (206) 131 Lactate (214) 17 Large vessel disease (214) 11 Lateral TLE (215) 21 Lazaroid (215) 87 LDL-apheresis (216) 179 LDL phenotype B (214) 11 LDL receptor (213) 7 Leukoencephalopathy (208) 93, (216) 183 Levodopa (212) 47, (216) 81 Lewy body (211) 29 Limb-girdle muscular dystrophy (LGMD) (211) 23 Local cooling (209) 55 Longitudinal study (216) 113 Long-term depression (LTD) (211) 43 Long-term potentiation (LTP) (211) 43 Low-grade glioma (214) 43 Lumbosacral radiculography (206) 85
Lymphocyte subsets (216) 61 Lymphocytes (214) 27 Lymphoid follicle (215) 119 Lymphomatoid granulomatosis (213) 67 Machado – Joseph disease (215) 45 Macrophage (208) 43 Macrophage colony-stimulating factor (M-CSF) (208) 43 Macrophages (214) 27 Madras motor neuron disease (209) 13 Madras motor neuron disease variant (209) 13 Magnesium (216) 95 Magnetic resonance imaging (206) 27, (206) 175, (206) 157, (208) 113, (211) 75, (212) 11, (213) 83, (214) 37, (215) 45, (216) 11 Magnetic resonance imaging (MRI) (206) 145, (208) 93, (210) 57 Magnetic resonance spectroscopy (207) 59 Magnetization transfer (206) 157 Mathematical model (216) 1 Matrix metalloproteinases (206) 43 Mechanical insufflation – exsufflation (209) 111 Mechanically assisted cough (209) 111 MELAS (216) 11 Membrane (216) 23 Mental calculation span (209) 19 Mesial (215) 21 Metabolism (216) 23 Methylenetetrahidrofolate reductase (MTHFR) (207) 19 Methylprednisolone (216) 61 Mice (208) 9 Microglia (215) 95 Middle cerebral artery (208) 71, (212) 59 Middle latency auditory-evoked potentials (207) 31 Migraine (213) 7, (216) 17 Mini-mental state examination (MMSE) (216) 105 Mite (209) 5 Mitochondria (206) 23, (207) 51, (208) 87 Mitochondrial DNA (211) 63 Mitochondrial encephalomyopathy (211) 63 Mitochondrial enzyme activity (214) 17 Mitochondrial myopathy (209) 61, (211) 63 Mitoxantrone (206) 203 Mixed connective tissue disease (215) 119 Miyoshi myopathy (MM) (211) 23 MMP-2 (207) 71 MMP-9 (207) 71 Molecular mimicry (210) 41 Monoamine oxidase inhibitor (206) 79 Monocyte chemoattractant protein-1 (MCP-1) (208) 43 Morphometry (210) 57 Motor amplitude (210) 83 Motor cortex (208) 79 Motor evoked potentials (216) 67 Motor neuron (206) 109, (208) 67 Motor neuron disease (209) 13, (214) 49, (216) 95 Motor neuron(s) (207) 51 Motor recovery (207) 25, (215) 13 Motor threshold (215) 75 Mouse (210) 11 Movement disorders (206) 59 MPTP (208) 9 MRI (206) 123, (206) 181, (206) 209, (208) 57, (209) 69, (210) 73, (211) 49, (211) 85, (212) 85, (213) 67, (215) 9, (216) 169 mRNA expression (216) 109 MR venography (215) 9 MS disease markers (212) 21 mtDNA mutation (214) 17 Multi-minicore disease (206) 71
Cumulative Subject Index, Volumes 206 – 216 (2003) Multiple sclerosis (206) 7, (206) 27, (206) 49, (206) 123, (206) 135, (206) 139, (206) 145, (206) 153, (206) 165, (206) 175, (206) 181, (206) 187, (206) 209, (208) 57, (209) 93, (210) 73, (211) 49, (211) 55, (211) 67, (212) 11, (213) 1, (214) 7, (214) 27, (215) 37, (215) 79, (216) 33, (216) 61, (216) 89, (216) 113, (216) 169 Multiple sclerosis drug therapy (206) 123 Multiple sclerosis (MS) (206) 193 Multiple system atrophy (211) 85 Multi-unit activity (212) 59 Muscle (208) 87 Muscle activation threshold (207) 25 Muscle atrophy (206) 109 Mutation (206) 65, (216) 43 Mutation analysis (211) 23 Myasthenia gravis (212) 31 Myelin-associated glycoprotein (MAG) (207) 43 Myelin basic protein (206) 7 Myelin oligodendrocyte glycoprotein (206) 7, (211) 67 Myelin proteins (206) 7 Myelin proteolipid protein (206) 7 Myelitis (209) 5 Myoclonus (209) 75 Myopathy (214) 49 Myotonic dystrophy (207) 31, (208) 87 NADPH-D (209) 31 L-NAME (215) 31 Nationwide survey (209) 5 Nerve conduction studies (214) 21 Nerve injury (211) 43 Nervous system (207) 37 Neuralgic amyotrophy (215) 111 Neural plasticity (216) 143 Neurodegeneration (207) 51, (207) 71 Neurodegenerative disorders (206) 23 Neurofibrillary tangles (208) 17 Neuroimaging (212) 85 Neuromuscular stimulation (207) 25 Neuronal antibodies (206) 131 Neuronal apoptosis (206) 91 Neuronal plasticity (208) 79 Neurons (209) 31 Neuropathy (206) 17 Neurophysiological study (210) 73 Neuroprotection (208) 9, (215) 31 Neuropsychological evaluation (209) 105 Neuropsychological test (213) 19 Neurosarcoidosis (208) 113, (211) 67 Neurotrauma (216) 23 Neutralizing antibody (215) 3 Nitrate (208) 1 Nitric oxide (208) 1 Nitrite (208) 1 NMDA (215) 31 NMDA receptor glycine site (210) 53 N-methyl-norsalsolinol (216) 109 NMR spectroscopy (212) 21 Nodular infiltrates (215) 119 Non-invasive positive pressure ventilation (209) 111 Non-invasive respiratory aids (209) 111 Normal brain aging (211) 15 Normal human cerebral cortex (211) 75 NOS isoforms (215) 31 Nosology (216) 127 NO synthase, Ca2+ signaling (209) 47 Notch (212) 79
211
Nucleus (210) 47 Number (208) 31 6-OHDA (216) 135 O – H2O PET (212) 85 Oligodendrocytes (206) 181 ONO-2506 (208) 9 ONO-1714 (215) 31 Opioid receptor (216) 109 Optic atrophy (209) 13 Optic neuritis (211) 49 Orthostatic hypotension (208) 71 Osmotic agent (209) 69 Oxidative stress (216) 135 Oxygen – glucose deprivation (216) 23 15
P300 (211) 15 Pain (212) 85 Painful neuropathy (215) 111 Painful sensory neuropathy (214) 3 Palliative care (209) 79 Paraneoplastic syndrome (213) 77 Parasympathetic nervous system (215) 79 PARK2 (207) 11 Parkinson (215) 105 Parkinson’s disease (206) 79, (207) 11, (208) 9, (209) 19, (209) 41, (209) 87, (211) 85, (212) 47, (212) 55, (213) 61, (215) 51, (216) 81, (216) 163 Parkinson’s disease (PD) (216) 105 Partial agonist (210) 53 PASAT (213) 29 Pathology (206) 17, (206) 165, (206) 175, (208) 101 Pattern recognition (212) 21 PC12 cell (216) 135 Peg insertion (213) 61 Percutaneous electric nerve stimulation (208) 79 Peripheral circulation (216) 17 Peripheral neuropathy (214) 49 Persistent vegetative state (212) 85 PET (210) 23 Phenotype (213) 25 Phosphene threshold (215) 75 Phosphorylated extracellular signal-regulated kinase (p-ERK) (215) 57 Phosphorylated serine/threonine kinase AKT (p-AKT) (215) 57 Photoplethysmography (216) 17 Pick’s disease (206) 97, (216) 127 Plasma exchange (206) 109, (210) 105 Plethysmography (216) 17 31 P-Magnetic resonance spectroscopy (214) 17 Polymorphisms (210) 77 Polyneuropathy (210) 19, (213) 55 Pontine base (215) 45 Pontine tegmentum (215) 45 Poser diagnostic criteria (214) 7 Positron emission tomography (209) 105 Positron emission tomography (PET) (215) 71 Post-encephalitic parkinsonism (206) 79 Posterior inferior cerebellar artery (207) 1 Posterior interosseous nerve (215) 111 Posterior spondylolisthesis (206) 39 Post-hypoxic (210) 23 Pramipexole (216) 81 Predictive factors (212) 31 Prefrontal cortex (209) 41, (211) 5 Pregnancy (216) 33 Presbycusis (216) 143 Presenilin 1 (209) 75
212
Cumulative Subject Index, Volumes 206 – 216 (2003)
Pretangle neurons (208) 17 Prevalence (213) 1, (214) 7, (216) 89 Prevalence rate (211) 49 Primary and secondary progressive (206) 153 Primary cultured neurons (215) 31 Primary progressive aphasia (206) 97 Primary progressive multiple sclerosis (206) 157, (206) 215 Prognostic indicator (215) 63 Progressive multiple sclerosis (206) 203, (211) 81 Progressive supranuclear palsy (211) 85 Progressive supranuclear palsy (PSP) (210) 57 Prospective study (215) 63 14-3-3 protein (212) 11 Pseudo-dominant inheritance (207) 11 Pseudotumor cerebri (215) 9 PTT (212) 75 Pulse sequence (216) 169 Purkinje cell (208) 51 Quality-of-life (209) 65 Quality of life (209) 79, (216) 113 Quantitative PCR (207) 87 Radial nerve palsy (215) 111 Radiation necrosis (209) 115 Radiosurgery (209) 115 Radiotherapy (214) 43 Rat (211) 5, (212) 59, (216) 109 Rat brain (209) 47 Reactive oxygen species (207) 51 Real-time PCR (210) 11 Recurrence (206) 31 Recurrent coma (209) 101 Regional cerebral blood flow (209) 25, (209) 41 Regucalcin (209) 47 Relapse (210) 105 Relapses (206) 123 Relapsing (206) 135 Relapsing – remitting (206) 153 Relapsing-remitting (216) 113 Relapsing – remitting multiple sclerosis (215) 3 Relaxation time (209) 69 Remitting (206) 135 Remyelination (206) 181, (206) 193 Reperfusion (215) 87, (216) 23 Repetitive transcranial magnetic stimulation (209) 41 Reproducibility (216) 169 Reproductive immunology (216) 33 Respiratory chain (206) 23 Resuscitation (210) 23 Reticular formation (212) 1 Retinol (215) 51 Retrosplenium of corpus callosum (210) 95 Revised version of Hasegawa’s Dementia Scale (HDSR) (216) 105 Rivastigmine (206) 23, (216) 119 RNase protection assay (210) 11 Rostral interstitial nucleus of the medial longitudinal fasciculus (riMLF) (210) 57 Rostral midbrain (210) 57 Rural (209) 65 SCA 3 (213) 25 Scavenger receptors (210) 11 Secondary progression (206) 209 Secondary progressive MS (206) 131 Secondary progressive multiple sclerosis (206) 199 Sensorimotor deficit (212) 59
Sensory neuropathy (214) 3 Septicemia (208) 25 Serotonin (211) 5 Serotonin receptor (216) 109 Sexual dimorphism (209) 93 Sexual dysfunction (210) 73 SF-36 (211) 55 Side effects (216) 113 Single photon emission computed tomography (209) 25, (213) 19 Single unit responses (216) 143 Skin (208) 67 Small fibre neuropathy (208) 105, (214) 3 Small subcortical infarct (216) 55 Small vessel disease (214) 11 Smoking (216) 163 Somatosensory evoked potentials (216) 67 Sound exposure (216) 143 South Africa (216) 47 Spain (216) 89 Spastic paraplegia (210) 35 Spastin (210) 35 SPECT (209) 41, (216) 119 Spectral analysis (208) 71 SPG4 (210) 35 SPG3A (216) 43 Spheroid (208) 67 Sphincteric dysfunction (210) 73 Spinal cord (214) 27 Spinal cord infiltrating cells (212) 37 Spinal nerve root sleeves (206) 85 Spinocerebellar ataxia, or inherited ataxias (216) 47 Spinocerebellar atrophy (213) 25 Spinocerebellar degeneration (210) 53 Statins (208) 105 Status epilepticus (211) 37 St. Bonaventure (213) 15 St. Francis (213) 15 Stroke (207) 25, (210) 77, (215) 13 Stroke classification (207) 65 Stroke-like episodes (214) 17 Stroke model (212) 59 Subacute sclerosing panencephalitis (207) 59 Subependymal vein (215) 115 Subgroup (215) 63 Sudden coma (212) 99 Sudden unexplained death in epilepsy (216) 153 Superoxide dismutase (216) 95 Superoxide dismutase 1 (SOD1) (206) 65, (215) 57 Suprachiasmatic nucleus (212) 93 Supranuclear gaze palsy (210) 57 Survey (211) 37 Sympathetic nervous system (215) 79 Sympathetic skin response (208) 105, (214) 21 Synapse (210) 5 a-Synuclein (211) 29 Systemic cooling (209) 55 Systemic hypotension (207) 1 Taiwanese (209) 87 Target formations (206) 71 T1 black holes (208) 57 Tea (216) 163 Temperature (209) 55 Temporal artery (215) 27 Temporal lobe epilepsy (215) 21 Temporal pattern (216) 99 Th1 (216) 61
Cumulative Subject Index, Volumes 206 – 216 (2003) The central nervous system involvement (207) 31 The parkin gene (207) 11 Therapeutics (206) 215 Therapy (210) 19, (216) 95 Thermal hyperalgesia (211) 43 Thrombomodulin (212) 55 Thymectomy (212) 31 Thymus (212) 31 TIA (207) 5 TIMP-1 (207) 71 TIMP-2 (207) 71 T2 lesions (208) 57 Tocopherol (215) 51 tonic – clonic seizure (209) 75 Trail Making Test (209) 19 Transcranial (207) 65 Transcranial Doppler (210) 31 Transcranial magnetic stimulation (210) 83, (211) 5, (213) 35, (215) 75 Transcutaneous electrical nerve stimulation (TENS) (211) 43 Transection (206) 165 Transgenic mouse (216) 95 Transient global amnesia (210) 95 Transvenous embolization (215) 115 Transverse – sigmoid sinuses (215) 115 Traumatic spinal cord injury (209) 55 Treatment (206) 79 Treatment choices (209) 79 Treatment trials (206) 139 Triamcinolone acetonide (211) 81 Tropical spastic paraparesis (206) 17 Tuberculoma (208) 109 Tuberculous meningitis (208) 109 Tumor growth (216) 1 Tumor invasion (216) 1 Tumor necrosis factor-alpha (209) 93 Tumor necrosis factor (TNF) (210) 19 TUNEL (208) 17 Turner’s syndrome (213) 83 Tyrosine hydroxylase (215) 105
213
U-74389G (215) 87 Ultrasonography (207) 19, (207) 65 Ultrasound (210) 31 Unweighting (210) 5 Urine (212) 21 Urodynamic study (210) 73 Vanadium (208) 1 Variable number tandem repeat polymorphism (209) 87 Varicella-Zoster virus (VZV) (215) 27 Vascular (212) 79 Vascular damage (206) 187 Vascular parkinsonism (215) 51 Vasculitis (208) 101 Veins (208) 101 Vertebral artery stenosis (207) 1 Video-assisted thoracoscopic extended thymectomy (VATET) (212) 31 Viliuisk encephalomyelitis (212) 69 Viral load (207) 87 Visual evoked potential (VEP) (206) 193 Visual loss (216) 11 Vitamin A (215) 51 Vitamin B12 deficiency (216) 183 Vitamin C (215) 51 Vitamin E (215) 51 Western blot (212) 11 Western blot analysis (207) 43 Working memory (208) 31, (209) 19 X-linked Charcot – Marie – Tooth (207) 77 Zoster myelopathy (212) 7 Zoster paresis (212) 7 Zoster sine herpete (212) 7 Z-score (210) 65
Cumulative Subject Index, Volumes 206–216 (2003) A Japanese family (210) 91 ABCA1 (210) 11 Acetazolamide (210) 91 Active neuromuscular stimulation (215) 13 Acute disseminated encephalomyelitis (206) 27 Acute inflammatory demyelinating polyneuropathy (210) 105 Acute motor axonal neuropathy (210) 41, (211) 93 Adhesion molecule (215) 119 Adhesion molecules (212) 37 Adult-onset (207) 59 A-y fibers (216) 67 Age (209) 25 Aging (207) 37, (209) 47, (214) 37, (216) 143 AIDS (208) 39 Airway secretions management (209) 111 ALS treatment (209) 111 Alterated splice site (212) 75 Alzheimer’s disease (208) 17, (208) 31, (209) 25, (210) 11, (215) 71, (216) 119, (216) 127 Alzheimer’s disease (AD) (216) 105 21-Aminosteroids (215) 87 AMPA/kainate receptor (206) 91 Amyotrophic lateral sclerosis (206) 65, (206) 91, (207) 51, (208) 67, (209) 79, (210) 83, (211) 85, (213) 47, (216) 95 Amyotrophic lateral sclerosis (ALS) (215) 57 Anatomy (211) 75 Anesthesia (211) 43 Angiocentric immunoproliferative lesions (213) 67 Angioencephalopathy (208) 101 Angiotensin-converting enzyme (210) 77 Anterior spinal artery (207) 1 Antibodies (211) 67 a-1-Antichymotrypsin (210) 77 Anticoagulant therapy (212) 99 Anti-GAD autoantibody (208) 51 Anti-ganglioside antibodies (213) 11 Anti-ganglioside antibody (210) 99, (211) 89 Anti-GM1 antibody (210) 41 Anti-GM1b antibody (210) 41 Anti-GQ1b antibody (210) 105 Anti-GT1a antibody (210) 105 Anti-Hu associated paraneoplastic encephalomyelitis (213) 77 Anti-MAG antibodies (207) 43 Anti-MAG polyneuropathy (207) 43 Antiparkinsonian agents (212) 55 Antiplatelets (207) 5 Anxiolytic effect (211) 5 Apolipoprotein E (210) 77, (211) 15 Apolipoprotein E genotype (206) 31 Apomorphine (215) 105 Apoptosis (207) 51, (208) 17, (214) 27 Apparent diffusion coefficient (216) 11 Architecture (210) 47 Arterial occlusive diseases (207) 65 Artery (212) 79
doi:10.1016/S0022-510X(03)00323-X
Asclepius (213) 15 Ascorbate (215) 51 Assay (208) 1 Association study (209) 87, (213) 7 Astrocytes (208) 9 Asymptomatic stroke (214) 37 Ataxia (210) 53 Atheroscrelosis (207) 19 Atlastin (216) 43 Atopic dermatitis (206) 39 Atopic myelitis (206) 39 Atopy (206) 109, (209) 5 Atrophy (208) 57, (210) 5, (215) 45, (216) 169 Attention (213) 29 Attentional set-shifting (209) 19 Auditory midbrain (216) 143 Australia (213) 1 Autoimmunity (213) 55 Automated (216) 169 Autonomic nervous system (213) 47, (215) 79 Autonomic nervous system disorder (216) 17 Axon (206) 165 Axonal degeneration (210) 41 Axonal injury (206) 187 Axonal neuropathy (214) 3 Axonal transport blockage (211) 29 Axonal transport substances (211) 29 Baculovirus p35 gene (216) 135 Baroreflex (213) 47 Basal ganglia (206) 27 aB-crystallin (206) 71 BDNF (215) 37 Best frequency (216) 143 Bickerstaff’s brainstem encephalitis (211) 89 Bilateral frontal polymicrogyria (213) 83 Binding antibody (215) 3 Blood – brain barrier (215) 87 Blood donors (214) 49 Body fluids (208) 1 Body weight (206) 85 Bovine gangliosides (216) 99 Brain (210) 11, (210) 23 Brain death (210) 31 Brain edema (215) 87 Brain infarction (210) 95 Brain ischemia (212) 99 Brain parenchymal fraction (208) 57 Brainstem (208) 93, (208) 101 CAG repeat (215) 45 CAG repeats (216) 47 Calculation (208) 31 Campylobacter jejuni (210) 41, (210) 99, (213) 55 Cardiac autonomic modulation (216) 153
208
Cumulative Subject Index, Volumes 206 – 216 (2003)
Cardiac [123I]-MIBG-SPECT (216) 153 Cardioembolism (212) 99 Caregiver (209) 79 Carotid artery (207) 19, (210) 31, (213) 19 Carotid endarterectomy (213) 19 Cauda equina (208) 113 Caudate nucleus (216) 109 CCM (212) 75 CD29 (216) 61 CD4 count (208) 39 Central autonomic nervous system diseases (215) 79 Central conduction time (210) 83 Central core disease (206) 71 Central nervous system (213) 67 Cerebellar ataxia (208) 51, (216) 183 Cerebellum (208) 51, (213) 35 Cerebral (216) 169 Cerebral autoregulation (208) 71 Cerebral blood flow (208) 71, (213) 19 Cerebral edema (209) 69 Cerebral infarction (209) 69, (212) 79 Cerebral spinal fluid (CSF) (206) 145 Cerebral venous thrombosis (215) 9 Cerebrospinal fluid (207) 71, (208) 39, (211) 67, (212) 11 Cerebrotendinous xanthomatosis (216) 179 Cerebrovascular disorders history (213) 15 Cervical spondylosis (206) 39 Chaperonin 10 (212) 37, (216) 33 Charcot – Marie – Tooth disease (210) 61, (211) 93 Chemokine (208) 43 Chemokine receptor (216) 61 Chemoreflex (213) 47 Chenodeoxycholic acid (216) 179 Chinese (216) 55, (216) 81, (216) 163 Cholestanol (216) 179 Cholesterol (210) 11 Cholinesterase inhibitors (216) 119 Chorea (208) 109 Christus Medicus (213) 15 Chromosome 19 (213) 7 Chronic brain inflammation (212) 69 Chronic inflammatory demyelinating polyneuropathy (208) 39 Chronic inflammatory demyelinating polyneuropathy (CIDP) (208) 43, (210) 19 Circadian rhythm (212) 93 Circumscribed atrophy (209) 105 Citicoline (215) 105 Citrullinaemia (209) 101 Clinical characteristics (206) 131 Clinical Dementia Rating (215) 71 Clinical epidemiology (215) 63 Clinical – MRI correlation (206) 139 Clustering/random arrangement (211) 63 CMTX (207) 77 CNS inflammation (206) 49 Coagulation system (212) 55 Coffee (216) 163 Cognitive function (213) 19 Cognitive functions (211) 15 Cognitive impairment (216) 105 Color discrimination (213) 61 Color vision (213) 61 Combined treatment (216) 179 Complex III deficiency (208) 87 Complex partial status epilepticus (213) 77 Complication (209) 115 Computed tomography (CT) (208) 93
Conduction block (213) 11 Congenital hypomyelination (210) 61 Congenital myopathies (206) 71 Connexin 32 mutation (207) 77 Controlled trials (206) 123 Coordinated eye and head movements (213) 35 CopaxoneR (215) 37 Cores (206) 71 Cortex (211) 85 Cortical excitability (215) 75 Cortical threshold (210) 83 Corticobasal degeneration (206) 97, (208) 31, (216) 127 Corticobasal degeneration syndrome (216) 127 Corticosteroids (208) 113 CSF (206) 43, (207) 87 CTG repeat (207) 31 CT scan (208) 25 Cultured neurons (206) 91 Cutaneous silent period (216) 67 Cu/Zn superoxide dismutase gene (206) 65 CXCR3 (216) 61 D-Cycloserine (210) 53 Cytoarchitecture (211) 75 Cytochrome b mutation (209) 61 Cytochrome c oxidase deficiency (211) 63 Cytochrome oxidase (212) 93 Cytokine (208) 43, (213) 11 Cytokines (215) 95, (216) 33 Cytomegalovirus (213) 55 Decreased saccadic latency (213) 35 Dejerine – Sottas syndrome (210) 61 Delayed-type hypersensitivity reaction (212) 37 Dementia (206) 23, (208) 87, (209) 105, (210) 77, (212) 79, (214) 37, (216) 119, (216) 169 Dementia with Lewy bodies (211) 29 Dementia with Lewy bodies (DLB) (216) 105 Demyelination (206) 187, (210) 19, (212) 37 Depression (209) 79, (211) 55 Developing country (209) 65 DGGE (210) 61 Diagnosis (210) 31 Diffuse brain disorders (213) 29 Diffuse neurofibrillary tangles with calcification (209) 105 Diffusion tensor (206) 157 Diffusion tensor MRI (206) 27 Diffusion-weighted imaging (210) 95, (212) 99 Diffusion-weighted MR (209) 101 Digit backward span (209) 19 Disability (206) 165, (206) 209, (209) 65 Disability evaluation (208) 57 Disease activity (211) 67 Disease progression (206) 123 Disuse (210) 5 L-DOPA sensitive Dystonia (213) 25 Dopamine (208) 9 Dopamine transporter gene (209) 87 Doppler (207) 65, (208) 71 Dose response (214) 43 Dural arteriovenous fistula (215) 115 Dynamics (212) 47 Dysconjugacy (210) 65 Dysferlin (211) 23 Dystonia (206) 59 EAE (206) 49 Early ischemic change (212) 99
Cumulative Subject Index, Volumes 206 – 216 (2003) Early pregnancy factor (212) 37, (214) 27, (216) 33 Education, Personality (211) 15 EEG (213) 83 Efficacy (211) 81 EGR2 (210) 61 Electromyography (214) 21 Electron transport chain (206) 23 Electrophysiological study (211) 89 Elevated plus-maze test (211) 5 ELISA (207) 43 Emery-Dreifuss (210) 47 Endothelin-1 (212) 59 Endplate (210) 5 Epidemiology (212) 31, (213) 1, (214) 7 Epidermal nerve fibers (214) 3 Epilepsy (209) 65, (213) 83 Epilepsy/EEG (211) 37 Epilepsy surgery (216) 153 Episodic ataxia type 2 (EA-2) (210) 91 Epitope mapping (206) 7 Epitope specificity (206) 7 Estrogen (210) 11 Etanercept (EnbrelR) (210) 19 Evan’s blue (215) 87 Evoked potentials, Auditory (212) 1 Exercise intolerance (209) 61 Exonic deletion (207) 11 Experimental autoimmune encephalomyelitis (212) 37, (214) 27, (216) 33 Exteroceptive suppression (216) 67 Eye/head latencies (213) 35 Fabry’s disease (214) 21 Falls (212) 47 Familial ALS (206) 65 Familial Alzheimer’s disease (209) 75 FDG PET (212) 85 Femoral neuropathy (209) 119 [F-18]-FDG (210) 23 Fibrinolysis (212) 55 Filamin C (206) 71 First-pass amplitude (210) 65 Flexion myelopathy (206) 109 Flow cytometry (209) 93 Fluorodeoxyglucose (FDG) (215) 71 fMRI (213) 29 Folate (207) 19 Four-vessel occlusion (215) 87 Frequency (211) 23 Friedreich’s ataxia (206) 59 Frontal cortex (209) 41 Frontal lobe function (214) 37 Frontotemporal dementia (206) 97, (208) 31 Functional magnetic resonance imaging (206) 157 Functional status (209) 65 GABA (208) 51 GABAA receptor (208) 51 GABAB receptor (208) 51 Gadolinium enhancement (213) 67 Gait (212) 47 Galectin-1 (208) 67 Gallium scan (208) 113 Ganglioside (213) 55 Gastric haemorrhage (208) 25 Gene analysis (210) 91 Gene dosage analysis (207) 11 Gene expression in Andeans (207) 37
209
Gene regulation (215) 95 Genetic polymorphism (209) 87 Genetics (213) 7 Genotype (210) 77 Giant cell arteritis (215) 27 Glatiramer acetate (215) 37 Glia (209) 31 Glioma (216) 1 Glutamate (206) 91 Glutamic acid decarboxylase (208) 51 Glutathione (207) 51, (215) 105 GM1 (210) 99 GQ1b (211) 89 Guillain – Barre´ syndrome (208) 39, (210) 99, (211) 93, (213) 11, (213) 55, (216) 99 Guillain-Barre´ syndrome (210) 41, (211) 89 Guillain – Barre´ syndrome (GBS) (215) 63 Habituation (212) 1 HAM/TSP (207) 87 Haploinsufficiency (210) 35 Haplotype (207) 11 Health-related quality of life (211) 55 Heart rate variability (216) 153 Heat shock protein (216) 33 Helicobacter pylori (213) 55 Hemiplegia (213) 15 Heparanase (206) 49 Heparin-mimicking polyanionic compound (HMPAC) (206) 49 Hepatic cirrhosis (212) 93 Hepatic encephalopathy (212) 93 Hereditary motor and sensory neuropathies (207) 77 Hereditary spastic paraplegia (216) 43 Heteroplasmy (211) 63 Hippocampus (209) 31 History of medicine, Medieval (213) 15 HIV (208) 39 HLA (211) 49 HMG-CoA reductase inhibitor (216) 179 1H-MRS (215) 21 HMSN (210) 61 H2O2 (216) 135 Homocysteinemia (207) 19 Hourglass-like fascicular constriction (215) 111 HTLV-I (206) 17, (207) 87, (214) 49 HTLV-I antibody index (207) 87 HTLV-I associated myelopathy (206) 17 HTLV-I-associated myelopathy (214) 49 HTLV-I-associated myelopathy/tropical spastic paraparesis (207) 87 Human chronic hypoxia (207) 37 Huntington’s disease (212) 1 6-hydroxydopamine (215) 105 Hyperbaric oxygenation (209) 115 Hypertension (208) 93 Hypothermia (209) 55 Hypoxia (206) 187, (213) 47, (215) 57 ICAM-1 (211) 15 ICAM-1 meningitis (206) 43 Idiopathic intracranial hypertension (215) 9 IgE (209) 5 IL-8 (206) 43 IL-10 (206) 209 Iliacus muscle hematoma (209) 119 IL-23, IL-12, IL-23R, IL-12R (215) 95 Immunoblotting (211) 23 Immunocytochemistry (209) 31
210
Cumulative Subject Index, Volumes 206 – 216 (2003)
Immunoglobulin G (206) 123 Immunoglobulins (206) 7 Immunohistochemistry (207) 43, (208) 67, (211) 23, (215) 119 Immunomodulation (206) 49 Immunosuppression (206) 203 Impedance cardiography (208) 71 Incidence (213) 1, (216) 89, (216) 99 Increased saccadic velocity (213) 35 Inflammatory demyelination (212) 21 Inflammatory myopathy (215) 119 Information processing (213) 29 Insert mutation (210) 35 In situ hybridisation (215) 27 Insula (212) 85 Interferon-h (207) 59 Interferon beta (206) 199, (216) 113 Interferon beta-1a (206) 215 Interferon beta 1a (215) 3 Interferon beta 1b (215) 3 Interferon-gamma (209) 93 Interleukin-6 (211) 15 International cooperative ataxia rating scale (210) 53 Internuclear ophthalmoparesis (210) 65 Intervertebral disc degeneration (206) 39 Intracerebral haemorrhage (208) 25 Intracranial hypertension (215) 9 Intracranial large artery disease (216) 55 Intracranial sinus venous thrombosis (215) 9 Intramedullary spinal cord lesion (216) 67 Intrathecal (211) 81 Intrathecal IgG synthesis (212) 69 Intravenous immunoglobulin (206) 123, (210) 105 Intravenous immunoglobulin (IVIg) therapy (208) 43 Intraventricular hemorrhage (215) 115 In vivo microdialysis (211) 5 Iopamidol transfer (206) 85 Isatin (206) 79 Ischemic cerebrovascular disease (206) 31 Ischemic stroke (207) 5 Isoelectric focusing (212) 69 Japanese (211) 49 Japanese encephalitis virus (206) 79 Japanese pedigree (209) 75 Korean family (206) 65 Kosaka – Shibayama disease (209) 105 KRIT1 gene (212) 75 Laboratory markers (206) 131 Lactate (214) 17 Large vessel disease (214) 11 Lateral TLE (215) 21 Lazaroid (215) 87 LDL-apheresis (216) 179 LDL phenotype B (214) 11 LDL receptor (213) 7 Leukoencephalopathy (208) 93, (216) 183 Levodopa (212) 47, (216) 81 Lewy body (211) 29 Limb-girdle muscular dystrophy (LGMD) (211) 23 Local cooling (209) 55 Longitudinal study (216) 113 Long-term depression (LTD) (211) 43 Long-term potentiation (LTP) (211) 43 Low-grade glioma (214) 43 Lumbosacral radiculography (206) 85
Lymphocyte subsets (216) 61 Lymphocytes (214) 27 Lymphoid follicle (215) 119 Lymphomatoid granulomatosis (213) 67 Machado – Joseph disease (215) 45 Macrophage (208) 43 Macrophage colony-stimulating factor (M-CSF) (208) 43 Macrophages (214) 27 Madras motor neuron disease (209) 13 Madras motor neuron disease variant (209) 13 Magnesium (216) 95 Magnetic resonance imaging (206) 27, (206) 175, (206) 157, (208) 113, (211) 75, (212) 11, (213) 83, (214) 37, (215) 45, (216) 11 Magnetic resonance imaging (MRI) (206) 145, (208) 93, (210) 57 Magnetic resonance spectroscopy (207) 59 Magnetization transfer (206) 157 Mathematical model (216) 1 Matrix metalloproteinases (206) 43 Mechanical insufflation – exsufflation (209) 111 Mechanically assisted cough (209) 111 MELAS (216) 11 Membrane (216) 23 Mental calculation span (209) 19 Mesial (215) 21 Metabolism (216) 23 Methylenetetrahidrofolate reductase (MTHFR) (207) 19 Methylprednisolone (216) 61 Mice (208) 9 Microglia (215) 95 Middle cerebral artery (208) 71, (212) 59 Middle latency auditory-evoked potentials (207) 31 Migraine (213) 7, (216) 17 Mini-mental state examination (MMSE) (216) 105 Mite (209) 5 Mitochondria (206) 23, (207) 51, (208) 87 Mitochondrial DNA (211) 63 Mitochondrial encephalomyopathy (211) 63 Mitochondrial enzyme activity (214) 17 Mitochondrial myopathy (209) 61, (211) 63 Mitoxantrone (206) 203 Mixed connective tissue disease (215) 119 Miyoshi myopathy (MM) (211) 23 MMP-2 (207) 71 MMP-9 (207) 71 Molecular mimicry (210) 41 Monoamine oxidase inhibitor (206) 79 Monocyte chemoattractant protein-1 (MCP-1) (208) 43 Morphometry (210) 57 Motor amplitude (210) 83 Motor cortex (208) 79 Motor evoked potentials (216) 67 Motor neuron (206) 109, (208) 67 Motor neuron disease (209) 13, (214) 49, (216) 95 Motor neuron(s) (207) 51 Motor recovery (207) 25, (215) 13 Motor threshold (215) 75 Mouse (210) 11 Movement disorders (206) 59 MPTP (208) 9 MRI (206) 123, (206) 181, (206) 209, (208) 57, (209) 69, (210) 73, (211) 49, (211) 85, (212) 85, (213) 67, (215) 9, (216) 169 mRNA expression (216) 109 MR venography (215) 9 MS disease markers (212) 21 mtDNA mutation (214) 17 Multi-minicore disease (206) 71
Cumulative Subject Index, Volumes 206 – 216 (2003) Multiple sclerosis (206) 7, (206) 27, (206) 49, (206) 123, (206) 135, (206) 139, (206) 145, (206) 153, (206) 165, (206) 175, (206) 181, (206) 187, (206) 209, (208) 57, (209) 93, (210) 73, (211) 49, (211) 55, (211) 67, (212) 11, (213) 1, (214) 7, (214) 27, (215) 37, (215) 79, (216) 33, (216) 61, (216) 89, (216) 113, (216) 169 Multiple sclerosis drug therapy (206) 123 Multiple sclerosis (MS) (206) 193 Multiple system atrophy (211) 85 Multi-unit activity (212) 59 Muscle (208) 87 Muscle activation threshold (207) 25 Muscle atrophy (206) 109 Mutation (206) 65, (216) 43 Mutation analysis (211) 23 Myasthenia gravis (212) 31 Myelin-associated glycoprotein (MAG) (207) 43 Myelin basic protein (206) 7 Myelin oligodendrocyte glycoprotein (206) 7, (211) 67 Myelin proteins (206) 7 Myelin proteolipid protein (206) 7 Myelitis (209) 5 Myoclonus (209) 75 Myopathy (214) 49 Myotonic dystrophy (207) 31, (208) 87 NADPH-D (209) 31 L-NAME (215) 31 Nationwide survey (209) 5 Nerve conduction studies (214) 21 Nerve injury (211) 43 Nervous system (207) 37 Neuralgic amyotrophy (215) 111 Neural plasticity (216) 143 Neurodegeneration (207) 51, (207) 71 Neurodegenerative disorders (206) 23 Neurofibrillary tangles (208) 17 Neuroimaging (212) 85 Neuromuscular stimulation (207) 25 Neuronal antibodies (206) 131 Neuronal apoptosis (206) 91 Neuronal plasticity (208) 79 Neurons (209) 31 Neuropathy (206) 17 Neurophysiological study (210) 73 Neuroprotection (208) 9, (215) 31 Neuropsychological evaluation (209) 105 Neuropsychological test (213) 19 Neurosarcoidosis (208) 113, (211) 67 Neurotrauma (216) 23 Neutralizing antibody (215) 3 Nitrate (208) 1 Nitric oxide (208) 1 Nitrite (208) 1 NMDA (215) 31 NMDA receptor glycine site (210) 53 N-methyl-norsalsolinol (216) 109 NMR spectroscopy (212) 21 Nodular infiltrates (215) 119 Non-invasive positive pressure ventilation (209) 111 Non-invasive respiratory aids (209) 111 Normal brain aging (211) 15 Normal human cerebral cortex (211) 75 NOS isoforms (215) 31 Nosology (216) 127 NO synthase, Ca2+ signaling (209) 47 Notch (212) 79
211
Nucleus (210) 47 Number (208) 31 6-OHDA (216) 135 O – H2O PET (212) 85 Oligodendrocytes (206) 181 ONO-2506 (208) 9 ONO-1714 (215) 31 Opioid receptor (216) 109 Optic atrophy (209) 13 Optic neuritis (211) 49 Orthostatic hypotension (208) 71 Osmotic agent (209) 69 Oxidative stress (216) 135 Oxygen – glucose deprivation (216) 23 15
P300 (211) 15 Pain (212) 85 Painful neuropathy (215) 111 Painful sensory neuropathy (214) 3 Palliative care (209) 79 Paraneoplastic syndrome (213) 77 Parasympathetic nervous system (215) 79 PARK2 (207) 11 Parkinson (215) 105 Parkinson’s disease (206) 79, (207) 11, (208) 9, (209) 19, (209) 41, (209) 87, (211) 85, (212) 47, (212) 55, (213) 61, (215) 51, (216) 81, (216) 163 Parkinson’s disease (PD) (216) 105 Partial agonist (210) 53 PASAT (213) 29 Pathology (206) 17, (206) 165, (206) 175, (208) 101 Pattern recognition (212) 21 PC12 cell (216) 135 Peg insertion (213) 61 Percutaneous electric nerve stimulation (208) 79 Peripheral circulation (216) 17 Peripheral neuropathy (214) 49 Persistent vegetative state (212) 85 PET (210) 23 Phenotype (213) 25 Phosphene threshold (215) 75 Phosphorylated extracellular signal-regulated kinase (p-ERK) (215) 57 Phosphorylated serine/threonine kinase AKT (p-AKT) (215) 57 Photoplethysmography (216) 17 Pick’s disease (206) 97, (216) 127 Plasma exchange (206) 109, (210) 105 Plethysmography (216) 17 31 P-Magnetic resonance spectroscopy (214) 17 Polymorphisms (210) 77 Polyneuropathy (210) 19, (213) 55 Pontine base (215) 45 Pontine tegmentum (215) 45 Poser diagnostic criteria (214) 7 Positron emission tomography (209) 105 Positron emission tomography (PET) (215) 71 Post-encephalitic parkinsonism (206) 79 Posterior inferior cerebellar artery (207) 1 Posterior interosseous nerve (215) 111 Posterior spondylolisthesis (206) 39 Post-hypoxic (210) 23 Pramipexole (216) 81 Predictive factors (212) 31 Prefrontal cortex (209) 41, (211) 5 Pregnancy (216) 33 Presbycusis (216) 143 Presenilin 1 (209) 75
212
Cumulative Subject Index, Volumes 206 – 216 (2003)
Pretangle neurons (208) 17 Prevalence (213) 1, (214) 7, (216) 89 Prevalence rate (211) 49 Primary and secondary progressive (206) 153 Primary cultured neurons (215) 31 Primary progressive aphasia (206) 97 Primary progressive multiple sclerosis (206) 157, (206) 215 Prognostic indicator (215) 63 Progressive multiple sclerosis (206) 203, (211) 81 Progressive supranuclear palsy (211) 85 Progressive supranuclear palsy (PSP) (210) 57 Prospective study (215) 63 14-3-3 protein (212) 11 Pseudo-dominant inheritance (207) 11 Pseudotumor cerebri (215) 9 PTT (212) 75 Pulse sequence (216) 169 Purkinje cell (208) 51 Quality-of-life (209) 65 Quality of life (209) 79, (216) 113 Quantitative PCR (207) 87 Radial nerve palsy (215) 111 Radiation necrosis (209) 115 Radiosurgery (209) 115 Radiotherapy (214) 43 Rat (211) 5, (212) 59, (216) 109 Rat brain (209) 47 Reactive oxygen species (207) 51 Real-time PCR (210) 11 Recurrence (206) 31 Recurrent coma (209) 101 Regional cerebral blood flow (209) 25, (209) 41 Regucalcin (209) 47 Relapse (210) 105 Relapses (206) 123 Relapsing (206) 135 Relapsing – remitting (206) 153 Relapsing-remitting (216) 113 Relapsing – remitting multiple sclerosis (215) 3 Relaxation time (209) 69 Remitting (206) 135 Remyelination (206) 181, (206) 193 Reperfusion (215) 87, (216) 23 Repetitive transcranial magnetic stimulation (209) 41 Reproducibility (216) 169 Reproductive immunology (216) 33 Respiratory chain (206) 23 Resuscitation (210) 23 Reticular formation (212) 1 Retinol (215) 51 Retrosplenium of corpus callosum (210) 95 Revised version of Hasegawa’s Dementia Scale (HDSR) (216) 105 Rivastigmine (206) 23, (216) 119 RNase protection assay (210) 11 Rostral interstitial nucleus of the medial longitudinal fasciculus (riMLF) (210) 57 Rostral midbrain (210) 57 Rural (209) 65 SCA 3 (213) 25 Scavenger receptors (210) 11 Secondary progression (206) 209 Secondary progressive MS (206) 131 Secondary progressive multiple sclerosis (206) 199 Sensorimotor deficit (212) 59
Sensory neuropathy (214) 3 Septicemia (208) 25 Serotonin (211) 5 Serotonin receptor (216) 109 Sexual dimorphism (209) 93 Sexual dysfunction (210) 73 SF-36 (211) 55 Side effects (216) 113 Single photon emission computed tomography (209) 25, (213) 19 Single unit responses (216) 143 Skin (208) 67 Small fibre neuropathy (208) 105, (214) 3 Small subcortical infarct (216) 55 Small vessel disease (214) 11 Smoking (216) 163 Somatosensory evoked potentials (216) 67 Sound exposure (216) 143 South Africa (216) 47 Spain (216) 89 Spastic paraplegia (210) 35 Spastin (210) 35 SPECT (209) 41, (216) 119 Spectral analysis (208) 71 SPG4 (210) 35 SPG3A (216) 43 Spheroid (208) 67 Sphincteric dysfunction (210) 73 Spinal cord (214) 27 Spinal cord infiltrating cells (212) 37 Spinal nerve root sleeves (206) 85 Spinocerebellar ataxia, or inherited ataxias (216) 47 Spinocerebellar atrophy (213) 25 Spinocerebellar degeneration (210) 53 Statins (208) 105 Status epilepticus (211) 37 St. Bonaventure (213) 15 St. Francis (213) 15 Stroke (207) 25, (210) 77, (215) 13 Stroke classification (207) 65 Stroke-like episodes (214) 17 Stroke model (212) 59 Subacute sclerosing panencephalitis (207) 59 Subependymal vein (215) 115 Subgroup (215) 63 Sudden coma (212) 99 Sudden unexplained death in epilepsy (216) 153 Superoxide dismutase (216) 95 Superoxide dismutase 1 (SOD1) (206) 65, (215) 57 Suprachiasmatic nucleus (212) 93 Supranuclear gaze palsy (210) 57 Survey (211) 37 Sympathetic nervous system (215) 79 Sympathetic skin response (208) 105, (214) 21 Synapse (210) 5 a-Synuclein (211) 29 Systemic cooling (209) 55 Systemic hypotension (207) 1 Taiwanese (209) 87 Target formations (206) 71 T1 black holes (208) 57 Tea (216) 163 Temperature (209) 55 Temporal artery (215) 27 Temporal lobe epilepsy (215) 21 Temporal pattern (216) 99 Th1 (216) 61
Cumulative Subject Index, Volumes 206 – 216 (2003) The central nervous system involvement (207) 31 The parkin gene (207) 11 Therapeutics (206) 215 Therapy (210) 19, (216) 95 Thermal hyperalgesia (211) 43 Thrombomodulin (212) 55 Thymectomy (212) 31 Thymus (212) 31 TIA (207) 5 TIMP-1 (207) 71 TIMP-2 (207) 71 T2 lesions (208) 57 Tocopherol (215) 51 tonic – clonic seizure (209) 75 Trail Making Test (209) 19 Transcranial (207) 65 Transcranial Doppler (210) 31 Transcranial magnetic stimulation (210) 83, (211) 5, (213) 35, (215) 75 Transcutaneous electrical nerve stimulation (TENS) (211) 43 Transection (206) 165 Transgenic mouse (216) 95 Transient global amnesia (210) 95 Transvenous embolization (215) 115 Transverse – sigmoid sinuses (215) 115 Traumatic spinal cord injury (209) 55 Treatment (206) 79 Treatment choices (209) 79 Treatment trials (206) 139 Triamcinolone acetonide (211) 81 Tropical spastic paraparesis (206) 17 Tuberculoma (208) 109 Tuberculous meningitis (208) 109 Tumor growth (216) 1 Tumor invasion (216) 1 Tumor necrosis factor-alpha (209) 93 Tumor necrosis factor (TNF) (210) 19 TUNEL (208) 17 Turner’s syndrome (213) 83 Tyrosine hydroxylase (215) 105
213
U-74389G (215) 87 Ultrasonography (207) 19, (207) 65 Ultrasound (210) 31 Unweighting (210) 5 Urine (212) 21 Urodynamic study (210) 73 Vanadium (208) 1 Variable number tandem repeat polymorphism (209) 87 Varicella-Zoster virus (VZV) (215) 27 Vascular (212) 79 Vascular damage (206) 187 Vascular parkinsonism (215) 51 Vasculitis (208) 101 Veins (208) 101 Vertebral artery stenosis (207) 1 Video-assisted thoracoscopic extended thymectomy (VATET) (212) 31 Viliuisk encephalomyelitis (212) 69 Viral load (207) 87 Visual evoked potential (VEP) (206) 193 Visual loss (216) 11 Vitamin A (215) 51 Vitamin B12 deficiency (216) 183 Vitamin C (215) 51 Vitamin E (215) 51 Western blot (212) 11 Western blot analysis (207) 43 Working memory (208) 31, (209) 19 X-linked Charcot – Marie – Tooth (207) 77 Zoster myelopathy (212) 7 Zoster paresis (212) 7 Zoster sine herpete (212) 7 Z-score (210) 65